BioCryst Pharmaceuticals
BCRX
BCRX
63 hedge funds and large institutions have $25.4M invested in BioCryst Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
63
Increased
–
Reduced
–
Closed
–
Calls
$124K
Puts
$167K
Net Calls
-$43K
Net Calls Change
-$43K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAS
51
CTC Alternative Strategies
Chicago,
Illinois
| $18.4K | +$18.4K | +11,900 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $18K | +$18K | +11,582 | New |
|
|
PAM
53
Paradigm Asset Management
New York
| $17.4K | +$17.4K | +11,200 | New |
|
|
LWM
54
Lyons Wealth Management
Winter Park,
Florida
| $16K | +$16K | +10,000 | New |
|
55
AllianceBernstein
Nashville,
Tennessee
| $14K | +$14K | +9,136 | New |
|
56
Wells Fargo
San Francisco,
California
| $14K | +$14K | +9,151 | New |
|
|
BA
57
BlackRock Advisors
Wilmington,
Delaware
| $13K | +$13K | +8,239 | New |
|
|
TCIM
58
TIAA CREF Investment Management
New York
| $8K | +$8K | +4,886 | New |
|
59
Citigroup
New York
| $3K | +$3K | +2,190 | New |
|
60
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | +$2K | +1,600 | New |
|
|
RFC
61
Russell Frank Company
Seattle,
Washington
| $1K | +$1K | +342 | New |
|
|
WA
62
WFG Advisors
Dallas,
Texas
| $1K | +$1K | +600 | New |
|
63
Creative Planning
Overland Park,
Kansas
| $1K | +$1K | +800 | New |
|